Description
AOD-9604
AOD-9604 is a synthetic peptide fragment derived from human growth hormone (hGH), specifically the C-terminal region (176–191). It is currently being studied for its potential in obesity research and metabolic regulation.
Key Research Attributes:
-
Fat Breakdown (Lipolysis):
AOD-9604 is classified as a lipolytic peptide, meaning it supports the breakdown of stored fat. Studies have shown increased lipolytic activity in adipose tissue, particularly in animal models. -
Selective Action:
Unlike full-length hGH, AOD-9604 does not appear to affect blood sugar or insulin sensitivity significantly, making it a unique candidate for fat-loss research without the anabolic side effects of growth hormone. -
Beta-Adrenergic Interaction:
There is evidence suggesting AOD-9604 may also interact with the beta-adrenergic pathway, potentially enhancing its lipolytic effects and offering new insights into fat metabolism regulation.
AOD-9604 continues to attract interest for its targeted activity on fat cells and potential as a therapeutic agent in metabolic research.
For research purposes only. Not for human consumption.
